KMPR (KMPR)

$1.8B
Market Cap
13.1
P/E Ratio
1.14
Beta
4.28%
Dividend Yield
Piotroski 5/9Altman Z 0.7 DistressROIC−WACC -7.8%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 5/9, Altman Z 0.7.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The company's capital allocation efficiency is critically impaired, evidenced by a return on invested capital of 1.3% that falls substantially short of the weighted average cost of capital at 9.1%, creating a negative spread of -7.8%. This value destruction is underpinned by an ROE of 5.4% driven primarily by financial leverage rather than operational excellence, as indicated by a low asset turnover of 0.38x and modest net margins of 3.0%. Fundamental health metrics further deteriorate this picture; the Altman Z-Score of 0.7 signals significant distress risk, while a Piotroski F-Score of 5/9 suggests moderate financial weakness relative to peer standards.

Despite these operational headwinds, equity multiples remain compressed at a forward P/E of 13.1x, which appears disconnected from the underlying economic reality given the negative ROIC-WACC spread. A discounted cash flow analysis implies a fair value of $372, suggesting that current market pricing may be detached from intrinsic worth or reliant on aggressive growth assumptions not reflected in recent revenue data showing only 3.2% year-over-year expansion. The valuation disconnect raises questions about whether the market is anticipating a structural turnaround or if the low multiple merely reflects a deep discount for the observed fundamental deterioration and high distress probability.

Recent insider activity compounds these concerns, with net selling of $17,469 over the past 90 days indicating a lack of confidence from management regarding future prospects. When combined with the negative capital spread and elevated bankruptcy risk metrics, the risk-reward profile appears skewed toward downside pressure unless there is an unpriced catalyst for margin expansion or asset base optimization that could reverse the current trajectory of value erosion.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →7.1%9.1%11.1%
2%$471$326$245
3%$575$372$270
4%$746$438$303

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=9.1%, terminal growth 3%. Fair value $372 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

5/9
Piotroski F-Score
Average — mixed operational signals
0.7
Altman Z-Score
Distress Zone — below 1.8 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.

Profitability & Value Creation

3.0%
Net Margin
1.3%
ROIC
9.1%
WACC
ROIC − WACC Spread: -7.8%— Negative spread.
+3.2%
Revenue Growth (YoY)
-54.9%
Earnings Growth (YoY)
553.9M
Free Cash Flow
14%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

3.0%
Net Profit Margin
NI ÷ Revenue
×
0.38x
Asset Turnover
Revenue ÷ Assets
×
4.67x
Equity Multiplier
Assets ÷ Equity
=
5.4%
Return on Equity
⚠️ High equity multiplier — ROE is being amplified by leverage, not operational excellence.

Balance Sheet Health

3.67x
Debt / Equity
5.2x
Interest Coverage
3.0x
Net Debt / EBITDA
21.42%
FCF Yield
273.5M
EBITDA

Insider Activity (Last 90 Days)

Net Insider Flow
$-17,469
Net Selling
0
Buy Transactions
1
Sale Transactions
2026-02-06MCKINNEY SUZET MSold 1/8 qtrsSale$17,469
2026-02-03EVANS CARL THOMAS JR.Grant$190,031
2026-02-03HUNTON MATTHEW AGrant$258,783
2026-02-03ALEXANDER JAMES ALLENGrant$204,010
2026-02-03FLINT CHRISTOPHER WADEGrant$180,509

Open-market buys vs sells by company insiders. Source: yfinance.

Earnings Surprise History

Q4
✓ Beat
Est: $1.49
Act: $1.65
+10.9%
Q3
✗ Miss
Est: $1.51
Act: $1.30
-13.8%
Q2
✗ Miss
Est: $1.32
Act: $0.33
-75.0%
Q1
✗ Miss
Est: $0.86
Act: $0.25
-70.8%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

5.7
Forward P/E
PEG Ratio
0.66
Price/Book
1M
Avg Volume
$68.04
52W High
$28.41
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$35M
Tracked Passive Exposure
8
ETFs Holding KMPR
0.08%
Avg Weight in ETFs
$46B
Total ETF AUM

When investors buy or sell ETFs like KIE or SLYV, the fund manager is mechanically forced to buy or sell KMPR shares regardless of KMPR's individual fundamentals. We estimate $35M of passive capital is structurally linked to KMPR through 8 tracked ETFs. Passive flows have a limited but growing influence on KMPR's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in KMPR to visualize passive redemption contagion across ETFs and collateral stocks.

KMPR Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
KMPREpicenterSPSMETFVFHETFSPTMETFLNCHigh RiskOSCRUnknownGNWHigh RiskADBELow RiskSTCMed Risk
KMPR Price Drop (%)0

If KMPR (KMPR) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies LINCOLN NATIONAL CORP (LNC) as the most exposed collateral stock, sharing 3 ETFs with KMPR. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 9 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

KMPR Ownership Dynamics

Ticker
KMPR

Float lock-up computed from 10 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

KMPR Capital Efficiency

How efficiently does KMPR convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$554M
EBITDA
$274M
FCF Conversion
203%
Reinvestment Rate
-103%
203% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
1.3%
ROIC − WACC Spread
-7.8%

KMPR converts 203% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. However, the ROIC-WACC spread is negative (-7.8%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-083,008$29.40$88,435.2
2026-04-0686$30.62$2,633.32
2026-03-3174$30.15$2,231.1
2026-03-272,596$31.17$80,917.32
2026-03-2347$29.69$1,395.43
2026-03-063$32.56$97.68
2026-03-04115$31.89$3,667.35
2026-02-24182$30.78$5,601.96
2026-02-23683$32.32$22,074.56
2026-02-201,135$32.57$36,966.95
2026-02-106$34.10$204.6
2026-02-092,097$34.24$71,801.28
2026-01-23702$38.80$27,237.6
2025-12-242,213$40.63$89,914.19
2025-11-205$36.67$183.35
2025-10-3095$45.29$4,302.55
2025-10-0353$50.40$2,671.2
2025-10-0292$50.75$4,669

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare KMPR to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.